Showing results (41-50 of 64) with videos related to
Sort By:
Pageof 7
Molecular and Cellular Endocrinology|February 13, 2003
Overexpression of adrenomedullin gene markedly inhibits proliferation of PC3 prostate cancer cells in vitro and in vivoIbane Abasolo, Luping Yang, Riffat Haleem, et al.Chinese Medicine|January 26, 2024
Decoction regulating phytochemicals' micromorphology changes and anti-inflammation activity enhancements originated from herb medicine supermoleculesLuping Yang, Xiang Zhang, Zhijia Wang, et al.Expert Review of Gastroenterology & Hepatology|January 23, 2023
Comparative efficacy of glucagon-like peptide 1 (GLP-1) receptor agonists, pioglitazone and vitamin E for liver histology among patients with nonalcoholic fatty liver disease: systematic review and pilot network meta-analysis of randomized controlled trialsYunpeng Gu, Lei Sun, Yining He, et al.Angewandte Chemie (International Ed. in English)|August 8, 2026
Domino Effect in Epimer Self-Assembly Induces Diverse Hydrogel Properties for Biomedical ApplicationsYihang Zhao, Luping Yang, Zhiwei Wang, et al.Biomaterials|August 9, 2024
Orchestrated metal-coordinated carrier-free celastrol hydrogel intensifies T cell activation and regulates response to immune checkpoint blockade for synergistic chemo-immunotherapyLinying Wu, Wenmin Pi, Xuemei Huang, et al.Marine Pollution Bulletin|May 9, 2024
Per- and polyfluoroalkyl substances (PFASs) in bivalve molluscs from Shandong Province, China: Occurrence, distribution, and implications for human consumptionLijun Zhu, Yanni Jiao, Liyou Wang, et al.United European Gastroenterology Journal|November 2, 2024
Early colorectal cancer diagnosis: A novel methylated stool DNA model enhanced the diagnostic efficiencyPeng Yun, Kamila Kulaixijiang, Jiang Pan, et al.Frontiers in Public Health|December 6, 2019
The Play of Genes and Non-genetic Factors on Type 2 DiabetesMichael Mambiya, Mengke Shang, Yue Wang, et al.Frontiers in Pharmacology|March 30, 2023
Comparative efficacy of 5 sodium-glucose cotransporter protein-2 (SGLT-2) inhibitor and 4 glucagon-like peptide-1 (GLP-1) receptor agonist drugs in non-alcoholic fatty liver disease: A GRADE-assessed systematic review and network meta-analysis of randomized controlled trialsYunpeng Gu, Lei Sun, Wei Zhang, et al.Science Advances|June 24, 2026
GPAM mediates mitochondrial dysfunction and the progression of alcoholic liver disease through lipid remodelingZibin Zhan, Xuewen Liu, Zehua Li, et al.Pageof 7